RecruitingNot ApplicableNCT05694559

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics


Sponsor

M.D. Anderson Cancer Center

Enrollment

1,000 participants

Start Date

Nov 23, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To identify Black individuals who are eligible for genetic testing through trusted community organizations, and to connect Black individuals and their families to genetic testing and counseling so that they can know their cancer risk and how to decrease it.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to connect Black families in Houston, Texas to genetic counseling and testing for hereditary cancer risk. Using a simple online questionnaire and virtual counseling sessions, researchers want to make genetic testing more accessible for communities that are often underserved in healthcare. **You may be eligible if...** - You are 18 or older - You self-identify as Black or African-American - You are based in or near Houston, Texas - You are willing to sign a consent form to be contacted **You may NOT be eligible if...** - There are no listed exclusion criteria — anyone meeting the above criteria may participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALGenetic Testing and Counseling

Participants will complete testing

BEHAVIORALScreening Form

Participants will complete forms with demographics and history


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05694559


Related Trials